Opinion statement
Oncoplastic surgery (OPS) expands the indications and possibilities of breast-conserving surgery (BCS) by allowing for a wider cancer resection than lumpectomy. Ongoing investigation and reporting of OPS outcomes along with improvements in comprehensive training in breast surgical oncology will impact on awareness and lead to increased adoption of these techniques. Indications for OPS include concern about clear margins, poor tumor location (upper inner pole and lower quadrant), multifocality, need for skin excision, and poor candidacy for mastectomy and reconstruction. OPS has been proven to be oncological safe with comparable rates of complications, positive margins, and re-excisions with BCS. Additionally, OPS has a positive impact on the quality of life and self-esteem when compared with those patients that underwent BCT.
Similar content being viewed by others
References and Recommended Reading
Strach MC, et al. Optimise not compromise: the importance of a multidisciplinary breast cancer patient pathway in the era of oncoplastic and reconstructive surgery. Crit Rev Oncol Hematol. 2019;134:10–21.
Macmillan RD, McCulley SJ. Oncoplastic breast surgery: what, when and for whom? Curr Breast Cancer Rep. 2016;8:112–7.
Clough KB, et al. Conservative treatment of breast cancers by mammaplasty and irradiation: a new approach to lower quadrant tumors. Plast Reconstr Surg. 1995;96(2):363–70.
Galimberti V, et al. Central small size breast cancer: how to overcome the problem of nipple and areola involvement. Eur J Cancer. 1993;29A(8):1093–6.
Losken A, et al. A meta-analysis comparing breast conservation therapy alone to the oncoplastic technique. Ann Plast Surg. 2014;72(2):145–9.
Kopkash K, Clark P. Basic oncoplastic surgery for breast conservation: tips and techniques. Ann Surg Oncol. 2018;25(10):2823–8.
Rietjens M, et al. Long-term oncological results of breast conservative treatment with oncoplastic surgery. Breast. 2007;16(4):387–95.
Clough KB, et al. Oncoplastic techniques allow extensive resections for breast-conserving therapy of breast carcinomas. Ann Surg. 2003;237(1):26–34.
Carter SA, et al. Operative and oncologic outcomes in 9861 patients with operable breast cancer: single-institution analysis of breast conservation with oncoplastic reconstruction. Ann Surg Oncol. 2016;23(10):3190–8.
Blankensteijn LL, et al. The influence of surgical specialty on oncoplastic breast reconstruction. Plast Reconstr Surg Glob Open. 2019;7(5):e2248.
Kimball CC, et al. Trends in lumpectomy and oncoplastic breast-conserving surgery in the US, 2011–2016. Ann Surg Oncol. 2018;25(13):3867–73.
Losken A, et al. Current opinion on the oncoplastic approach in the USA. Breast J. 2016;22(4):437–41.
Regano S, et al. Oncoplastic techniques extend breast-conserving surgery to patients with neoadjuvant chemotherapy response unfit for conventional techniques. World J Surg. 2009;33(10):2082–6.
Losken A, Hart AM, Chatterjee A. Updated evidence on the oncoplastic approach to breast conservation therapy. Plast Reconstr Surg. 2017;140(5S Advances in Breast Reconstruction):14S–22S.
Campbell EJ, Romics L. Oncological safety and cosmetic outcomes in oncoplastic breast conservation surgery, a review of the best level of evidence literature. Breast Cancer (Dove Med Press). 2017;9:521–30.
Patel K, et al. An oncoplastic surgery primer: common indications, techniques, and complications in level 1 and 2 volume displacement oncoplastic surgery. Ann Surg Oncol. 2019;26(10):3063–70.
Clough KB, et al. Long-term results after oncoplastic surgery for breast cancer: a 10-year follow-up. Ann Surg. 2018;268(1):165–71.
Chatterjee A, et al. A consensus definition and classification system of oncoplastic surgery developed by the American Society of Breast Surgeons. Ann Surg Oncol. 2019;26(11):3436–44.
Clough KB, et al. Positive margins after oncoplastic surgery for breast cancer. Ann Surg Oncol. 2015;22(13):4247–53.
Fisher B, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233–41.
Veronesi U, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227–32.
Bosma SC, et al. Very low local recurrence rates after breast-conserving therapy: analysis of 8485 patients treated over a 28-year period. Breast Cancer Res Treat. 2016;156(2):391–400.
Mansell J, et al. Oncoplastic breast conservation surgery is oncologically safe when compared to wide local excision and mastectomy. Breast. 2017;32:179–85.
Pilewskie M, Morrow M. Margins in breast cancer: how much is enough? Cancer. 2018;124(7):1335–41.
Chen JY, et al. Comparison of oncoplastic breast-conserving surgery and breast-conserving surgery alone: a meta-analysis. J Breast Cancer. 2018;21(3):321–9.
Yiannakopoulou EC, Mathelin C. Oncoplastic breast conserving surgery and oncological outcome: systematic review. Eur J Surg Oncol. 2016;42(5):625–30.
Emiroglu M, et al. Oncoplastic reduction mammoplasty for breast cancer in women with macromastia: oncological long-term outcomes. Asian J Surg. 2017;40(1):41–7.
van Dongen JA, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10,801 trial. J Natl Cancer Inst. 2000;92(14):1143–50.
Losken A, et al. The oncoplastic reduction approach to breast conservation therapy: benefits for margin control. Aesthet Surg J. 2014;34(8):1185–91.
De La Cruz L, et al. Outcomes after oncoplastic breast-conserving surgery in breast cancer patients: a systematic literature review. Ann Surg Oncol. 2016;23(10):3247–58.
McIntosh J, O’Donoghue JM. Therapeutic mammaplasty--a systematic review of the evidence. Eur J Surg Oncol. 2012;38(3):196–202.
Wang K, et al. Prevalence of pain in patients with breast cancer post-treatment: a systematic review. Breast. 2018;42:113–27.
Cornelissen AJM, et al. Sensation of the autologous reconstructed breast improves quality of life: a pilot study. Breast Cancer Res Treat. 2018;167(3):687–95.
Temple CL, et al. Sensibility following innervated free TRAM flap for breast reconstruction: Part II. Innervation improves patient-rated quality of life. Plast Reconstr Surg. 2009;124(5):1419–25.
Cochrane RA, et al. Cosmesis and satisfaction after breast-conserving surgery correlates with the percentage of breast volume excised. Br J Surg. 2003;90(12):1505–9.
Chauhan A, Sharma MM. Evaluation of surgical outcomes following oncoplastic breast surgery in early breast cancer and comparison with conventional breast conservation surgery. Med J Armed Forces India. 2016;72(1):12–8.
Down SK, et al. Oncological advantages of oncoplastic breast-conserving surgery in treatment of early breast cancer. Breast J. 2013;19(1):56–63.
Losken A, et al. Oncoplastic breast reduction technique and outcomes: an evolution over 20 years. Plast Reconstr Surg. 2017;139(4):824e–33e.
Tong WM, et al. Obese women experience fewer complications after oncoplastic breast repair following partial mastectomy than after immediate total breast reconstruction. Plast Reconstr Surg. 2016;137(3):777–91.
Losken A, Pinell XA, Eskenazi B. The benefits of partial versus total breast reconstruction for women with macromastia. Plast Reconstr Surg. 2010;125(4):1051–6.
Nakada H, et al. Fat necrosis after breast-conserving oncoplastic surgery. Breast Cancer. 2019;26(1):125–30.
Kapadia SM, et al. Time to radiation after oncoplastic reduction. Ann Plast Surg. 2019;82(1):15–8.
Bartelink H, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881–10,882 trial. J Clin Oncol. 2007;25(22):3259–65.
Romestaing P, et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol. 1997;15(3):963–8.
Litiere S, et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol. 2012;13(4):412–9.
Punglia RS, et al. Impact of interval from breast conserving surgery to radiotherapy on local recurrence in older women with breast cancer: retrospective cohort analysis. BMJ. 2010;340:c845.
Huang J, et al. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol. 2003;21(3):555–63.
Hershman DL, et al. Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Breast Cancer Res Treat. 2006;99(3):313–21.
Tenofsky PL, et al. Surgical, oncologic, and cosmetic differences between oncoplastic and nononcoplastic breast conserving surgery in breast cancer patients. Am J Surg. 2014;207(3):398–402 discussion 402.
Shah C, Al-Hilli Z, Schwarz G. Oncoplastic surgery in breast cancer: do not forget the boost! Ann Surg Oncol. 2018;25(9):2509–11.
Furet E, et al. Plastic surgery for breast conservation therapy: how to define the volume of the tumor bed for the boost? Eur J Surg Oncol. 2014;40(7):830–4.
Khan J, et al. Oncoplastic breast conservation does not lead to a delay in the commencement of adjuvant chemotherapy in breast cancer patients. Eur J Surg Oncol. 2013;39(8):887–91.
Kronowitz SJ, et al. Practical guidelines for repair of partial mastectomy defects using the breast reduction technique in patients undergoing breast conservation therapy. Plast Reconstr Surg. 2007;120(7):1755–68.
Losken A, et al. Management algorithm and outcome evaluation of partial mastectomy defects treated using reduction or mastopexy techniques. Ann Plast Surg. 2007;59(3):235–42.
Munhoz AM, et al. Critical analysis of reduction mammaplasty techniques in combination with conservative breast surgery for early breast cancer treatment. Plast Reconstr Surg. 2006;117(4):1091–103 discussion 1104–7.
Spear SL, et al. Experience with reduction mammaplasty combined with breast conservation therapy in the treatment of breast cancer. Plast Reconstr Surg. 2003;111(3):1102–9.
Perry S, Kowalski TL, Chang CH. Quality of life assessment in women with breast cancer: benefits, acceptability and utilization. Health Qual Life Outcomes. 2007;5:24.
Winters ZE, Benson JR, Pusic AL. A systematic review of the clinical evidence to guide treatment recommendations in breast reconstruction based on patient- reported outcome measures and health-related quality of life. Ann Surg. 2010;252(6):929–42.
Aristokleous I, Saddiq M. Quality of life after oncoplastic breast-conserving surgery: a systematic review. ANZ J Surg. 2019;89(6):639–46.
Kanatas A, et al. Patient-reported outcomes in breast oncology: a review of validated outcome instruments. Tumori. 2012;98(6):678–88.
Chen CM, et al. Measuring quality of life in oncologic breast surgery: a systematic review of patient-reported outcome measures. Breast J. 2010;16(6):587–97.
Hart AM, et al. The psychosexual impact of partial and total breast reconstruction: a prospective one-year longitudinal study. Ann Plast Surg. 2015;75(3):281–6.
Veiga DF, et al. Quality-of-life and self-esteem outcomes after oncoplastic breast-conserving surgery. Plast Reconstr Surg. 2010;125(3):811–7.
Kelsall JE, et al. Comparing oncoplastic breast conserving surgery with mastectomy and immediate breast reconstruction: Case-matched patient reported outcomes. J Plast Reconstr Aesthet Surg. 2017;70(10):1377–85.
Di Micco R, et al. Standard wide local excision or bilateral reduction mammoplasty in large-breasted women with small tumours: surgical and patient-reported outcomes. Eur J Surg Oncol. 2017;43(4):636–41.
Losken A, et al. The impact of partial breast reconstruction using reduction techniques on postoperative cancer surveillance. Plast Reconstr Surg. 2009;124(1):9–17.
Piper M, et al. Comparison of mammographic findings following oncoplastic mammoplasty and lumpectomy without reconstruction. Ann Surg Oncol. 2016;23(1):65–71.
Dolan R, et al. Imaging results following oncoplastic and standard breast conserving surgery. Breast Care (Basel). 2015;10(5):325–9.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Isis Scomacao declares that there is no conflict of interest. Zahraa AlHilli declares that there is no conflict of interest. Graham Schwarz declares that there is no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Breast Cancer
Rights and permissions
About this article
Cite this article
Scomacao, I., AlHilli, Z. & Schwarz, G. The Role of Oncoplastic Surgery for Breast Cancer. Curr. Treat. Options in Oncol. 21, 94 (2020). https://doi.org/10.1007/s11864-020-00793-1
Accepted:
Published:
DOI: https://doi.org/10.1007/s11864-020-00793-1